.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

McKesson
Merck
Covington
Deloitte
Farmers Insurance
Colorcon
Teva
Daiichi Sankyo
Chubb
Fuji

Generated: September 23, 2017

DrugPatentWatch Database Preview

Tentative Approvals for: nevirapine

« Back to Dashboard
Applicant Generic Name NDA Strength Dosage Form
Ranbaxy
nevirapine
077429200MGTABLET; ORAL
Cipla Limited
nevirapine
20221250MGTABLET, FOR SUSPENSION; ORAL
Cipla Limited
nevirapine
202212100MGTABLET, FOR SUSPENSION; ORAL
Cipla Limited
nevirapine
207064400MGTABLET, EXTENDED RELEASE;ORAL
Aurobindo Pharma Ltd
nevirapine
02229950MGTABLET; ORAL
Mylan Labs Ltd
nevirapine
205921400MGTABLET, EXTENDED RELEASE;ORAL
Macleods Pharma
nevirapine
090688200MGTABLET; ORAL
Emcure Pharma
nevirapine
078887200MGTABLET; ORAL
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Queensland Health
Colorcon
Moodys
McKinsey
Chubb
Novartis
Federal Trade Commission
Citi
Cipla
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot